Advertisement

Sumatriptan Succinate Injection

[17 July 2014]

Products Affected - Description

 
Sumatriptan Succinate injection, JHP
6 mg/0.5 mL vial, 5 count (NDC 42023-0121-05)

Sumatriptan Succinate injection, Sagent
6 mg/0.5 mL vial, 5 count (NDC 25021-0703-60)
 
Sumatriptan Succinate injection, Sandoz
6 mg/0.5 mL vial, 5 count (NDC 00781-3174-14)
 
Sumatriptan Succinate injection, Teva
6 mg/0.5 mL, 5 count (NDC 00703-7351-02)

Alsuma injection, Pfizer
6 mg/ 0.5 mL prefilled single-use autoinjector (NDC 27505-0002-00
 
Sumatriptan Succinate injection, West-Ward
6 mg/0.5 mL vial, 5 count (NDC 00143-9638-05)

Reason for the Shortage

  • Sagent states the reason for the shortage is increased demand.
  • JHP could not provide a reason for the shortage.
  • GlaxoSmithKline could not provide a reason for the shortage.
  • Pfizer has had Alsuma on shortage since September 2013 due to manufacturing issues.
  • Teva has temporarily suspended the production of sumatriptan injection.

Available Products

Sumatriptan Succinate injection, AuroMedics
6 mg/0.5 mL vial, 5 count (NDC 55150-0173-01)
 
Sumatriptan Succinate injection, Caraco
6 mg/0.5 mL prefilled syringe and single-use autoinjector, 2 count (NDC 47335-0276-41)
 
Sumatriptan Succinate injection, Fresenius Kabi
6 mg/0.5 mL vial, 1 count (NDC 63323-0273-01)
 
Sumatriptan Succinate injection, Sagent
6 mg/0.5 mL prefilled syringe with needle, 2 count (NDC 25021-0703-70)

Sumatriptan Succinate injection, Sandoz
6 mg/0.5 mL prefilled syringe (refill for autoinjector), 2 count (NDC 00781-3173-07)
6 mg/0.5 mL kit (includes 2 prefilled syringes and autoinjector pen), (NDC 00781-3172-07)
4 mg/0.5 mL kit (includes 2 prefilled syringes and autoinjector pen) (NDC 00781-3169-07)
4 mg/0.5 mL prefilled syringe (refill for autoinjector), 2 count (NDC 00781-3170-07)
 
Imitrex injection, GlaxoSmithKline
6 mg/ 0.5 mL vials, 5 count (NDC 00173-0449-02)
6 mg/0.5 mL prefilled syringe (refill for autoinjector), 2 count (NDC 00173-0478-00)
6 mg/0.5 mL kit (includes 2 prefilled syringes and autoinjector pen) (NDC 00173-0479-00)
4 mg/0.5 mL prefilled syringe (refill for autoinjector), 2 count (NDC 00173-0739-02)
4 mg/0.5 mL kit (includes 2 prefilled syringes and autoinjector pen) (NDC 00173-0739-00)

Sumavel DosePro, Zogenix
6 mg/0.5 mL, needle-free single use injector unit, 6 count (NDC 43376-0106-06)

Estimated Resupply Dates

  • JHP has sumatriptan injection on long-term back order and the company cannot estimate a release date.
  • Sagent has sumatriptan vials on back order and the company estimates a release date of August 2014.
  • Sandoz has sumatriptan vials on back order and the company estimates a release date of mid-July 2014.
    Teva has sumatriptan injection unavailable and the company estimates product will be re-introduced in June 2015.
  • Pfizer has Alsuma on long-term back order and the company estimates a release date in September 2015.
  • West-Ward has sumatriptan on back order with an estimated release date in late-July to mid-August 2014. Short-dated product is available.

Related Shortages

Updated

July 17, 2014; June 24, 2014; June 5, 2014; May 22, 2014; April 15, 2014; March 31, 2014; March 27, 2014; February 27, 2014, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement